Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04581343
Brief Title: A Phase 1B Study of Canakinumab, Spartalizumab, Nab-paclitaxel, and Gemcitabine in Metastatic PC Patients (PanCAN-SR1)

First Submitted : September 14, 2020
First Submitted that Met QC Criteria : October 2, 2020
First Posted : October 9, 2020

Last Update Submitted that Met QC Criteria : January 26, 2021
Last Update Posted : January 27, 2021